Related references
Note: Only part of the references are listed.Benzodiazepines: the time for systematic change is now
Allison Schmitz
ADDICTION (2021)
Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
Jeon-Kyung Kim et al.
SCIENTIFIC REPORTS (2021)
Similarities and dissimilarities in the effects of benzodiazepines and specific serotonin reuptake inhibitors (SSRIs) in the defensive marble burying test: A systematic review and meta-analysis
Erez Langer et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
The completely randomised and the randomised block are the only experimental designs suitable for widespread use in pre-clinical research
Michael F. W. Festing
SCIENTIFIC REPORTS (2020)
A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward
Geoffrey de Brouwer et al.
COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE (2019)
Amygdaloid involvement in the defensive behavior of mice exposed to the open elevated plus-maze
Tatiani Sorregotti et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Revisiting the validity of the mouse forced swim test: Systematic review and meta-analysis of the effects of prototypic antidepressants
N. Z. Kara et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Dealing with the positive publication bias: Why you should really publish your negative results
Ana Mlinaric et al.
BIOCHEMIA MEDICA (2017)
Concordance and incongruence in preclinical anxiety models: Systematic review and meta-analyses
Farhan Mohammad et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
MATSAP: An automated analysis of stretch-attend posture in rodent behavioral experiments
Kevin S. Holly et al.
SCIENTIFIC REPORTS (2016)
Classics in Chemical Neuroscience: Diazepam (Valium)
Nicholas E. Calcaterra et al.
ACS CHEMICAL NEUROSCIENCE (2014)
50 years of hurdles and hope in anxiolytic drug discovery
Guy Griebel et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus
Paul J. Currie et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice
Kiersten S. Smith et al.
NEUROPHARMACOLOGY (2012)
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats
Yi-Tse Hsiao et al.
NEUROPHARMACOLOGY (2012)
Therapeutic effect of paroxetine on stress-induced gastric lesions in mice
Tomohisa Takahashi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice
C. K. Thoeringer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Context and strain-dependent behavioral response to stress
Katarzyna Nosek et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2008)
Serotonin transporter density and anxiolytic-like effects of antidepressants in mice
N. R. Mirza et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Alicia A. Walf et al.
NATURE PROTOCOLS (2007)
A combined marble burying-locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants
Laurent B. Nicolas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Nicotine antagonizes caffeine- but not pentylenetetrazole-induced anxiogenic effect in mice
H Kayir et al.
PSYCHOPHARMACOLOGY (2006)
Glutamate- and GABA-based CNS therapeutics
AC Foster et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Why most published research findings are false
JPA Ioannidis
PLOS MEDICINE (2005)
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
AP Carobrez et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
The ascent of mouse: Advances in modelling human depression and anxiety
JF Cryan et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The serotonergic system and anxiety
JA Gordon et al.
NEUROMOLECULAR MEDICINE (2004)
A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze
SM Korte et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
L Prut et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Strain differences in the anxiolytic effects of losartan in the mouse
PR Gard et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression?
DJP David et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Anxiety-like behavior in elevated plus-maze tests in repeatedly cold-stressed mice
T Hata et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice
EM Lepicard et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress
CM Padovan et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice
G Griebel et al.
PSYCHOPHARMACOLOGY (2000)
The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test
M Hascoet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)